* According to results of the 2013 Brandspark Best New Product Awards survey conducted by BrandSpark international in Canada November 8 2012 - December 31, 2012. For more information visit www.BestNewProductAwards.biz
*In clinical testing Abreva is proven to reduce healing time of cold sores to median
4.1 days vs. 4.8 days placebo.
To be sure this product is right for you, always read and follow the label.
All information appearing on this site is reserved for residents of Canada only. Copyright of GlaxoSmithKline group of companies Abreva is a registered trademark of the GlaxoSmithKline group of companies. All rights reserved.